Viking Therapeutics
VKTX
$64.93
Share price
1.69%
Change (1 day)
204.41%
Change (1 year)
Categories
Market capitalization of Viking Therapeutics (VKTX)
Market cap: $7.15 Billion
As of April 2024 Viking Therapeutics has a market cap of $7.15 Billion. This makes Viking Therapeutics the world's 2050th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Viking Therapeutics from 2015 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $7.15 B | 284.44% |
| 2023 | $1.86 B | 158.23% |
| 2022 | $0.72 B | 100.31% |
| 2021 | $0.35 B | -12.69% |
| 2020 | $0.41 B | -29.02% |
| 2019 | $0.58 B | 5.82% |
| 2018 | $0.54 B | 288.7% |
| 2017 | $0.14 B | 488.24% |
| 2016 | $24 M | -27.31% |
| 2015 | $33.02 M |
End of Day market cap according to different sources
On Apr 23rd, 2024 the market cap of Viking Therapeutics was reported to be:
$7.15 Billion
$7.15 Billion
$6.52 Billion
$7.16 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Ultragenyx RARE | $3.71 B | -48.10% | 🇺🇸 USA |
 Repligen
RGEN | $9.56 B | 33.64% | 🇺🇸 USA |
 Recro Pharma
REPH | $0.12 B | -98.28% | 🇺🇸 USA |